NeuroVoices: Dennis Rivet, MD, on Expanding the Role of GLP-1 RAs to Idiopathic Intracranial Hypertension and Beyond
Written by
Neurology Live
Published
0
comments
0
min
The Harold I. Nemuth Chair in Neurological Disorders at Virginia Commonweath University discussed the rationale, results, and future directions of GLP-1 RA therapy as a novel treatment strategy for idiopathic intracranial hypertension.